Prosecution Insights
Last updated: August 17, 2026

Examiner: TOTH, KAREN E

Tech Center 3700 • Art Units: 2884 3732 3735 3791 3794

This examiner grants 47% of resolved cases

Performance Statistics

46.7%
Allow Rate
-23.3% vs TC avg
840
Total Applications
+25.4%
Interview Lift
1736
Avg Prosecution Days
Based on 760 resolved cases, 2023–2026

Rejection Statute Breakdown

14.2%
§101 Eligibility
14.3%
§102 Novelty
37.6%
§103 Obviousness
29.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18948785 SOFTWARE APPLICATIONS RESIDING ON HANDHELD ANALYTE DETERMINING DEVICES Final Rejection ABBOTT DIABETES CARE INC.
18369100 ANALYTE MONITORING SYSTEMS AND METHODS Final Rejection ABBOTT DIABETES CARE INC.
17532755 ANALYTE MONITORING DEVICES AND METHODS Non-Final OA ABBOTT DIABETES CARE INC.
17779509 AUTOMATED SYSTEM FOR CONTROLLING THE BLOOD GLUCOSE LEVEL Non-Final OA Commissariat à l'Énergie Atomique et aux Énergies Alternatives
18042074 Physiological Data Collection Method and Apparatus, and Wearable Device Non-Final OA Huawei Technologies Co., Ltd.
18005359 BODY TEMPERATURE MEASUREMENT METHOD, ELECTRONIC DEVICE, AND STORAGE MEDIUM Non-Final OA HUAWEI TECHNOLOGIES CO., LTD.
18286693 MONITORING PHYSIOLOGIC PARAMETERS IN HEALTH AND DISEASE USING LIDAR Non-Final OA Mayo Foundation for Medical Education and Research
17996032 INGESTIBLE SAMPLING DEVICE Final Rejection Mayo Foundation for Medical Education and Research
18169400 SENSOR ATTACHMENT SYSTEM, RESPIRATORY GAS SENSOR, AND COMPATIBLE AIRWAY ADAPTOR Final Rejection NIHON KOHDEN CORPORATION
18056147 END TIDAL CARBON DIOXIDE MEASUREMENT DURING HIGH FLOW OXYGEN THERAPY Final Rejection COVIDIEN LP
18198431 BED WITH BED PRESENCE DETECTION USING TEMPERATURE SIGNALS Final Rejection Sleep Number Corporation
18100061 Biomarkers Predictive of Atopic Dermatitis Final Rejection Johnson & Johnson Consumer Inc.
17996911 SYSTEMS AND METHODS FOR ADMINISTERING A SMELL TEST FOR SARS CORONAVIRUSES AND COVID-19 Non-Final OA The General Hospital Corporation
18731841 DETERMINATION OF A USER’S GLYCATED HEMOGLOBIN LEVEL USING PULSE SPECTROSCOPY Non-Final OA Garmin International, Inc.
18742987 METHODS FOR DETECTING AND PREVENTING ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT Non-Final OA RAMOT AT TEL-AVIV UNIVERSITY LTD.
17904790 METHOD AND APPARATUS FOR PERFORMING SPATIAL FILTERING AND AUGMENTING ELECTROENCEPHALOGRAM SIGNAL, ELECTRONIC DEVICE, AND STORAGE MEDIUM Non-Final OA TIANJIN UNIVERSITY
18320270 Device And Method For Determining Glaucoma Final Rejection THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month